Subscribe To Our Newsletter
Abonnez-vous à notre bulletin
ROUND NINE RESULTS, BY COUNTRY
GFO Issue 110

ROUND NINE RESULTS, BY COUNTRY

Author:

Bernard Rivers

Article Type:
News

Article Number: 2

ABSTRACT Details are provided of the Board's decision regarding each eligible Round 9 proposal.

Based on advice from the TRP, the Board divided eligible Round 9 proposals into five Categories, as follows:

  • Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
  • Category 2: Proposals that are approved in principle, subject to the required clarifications being provided within a limited timeframe (8 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
  • Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
  • Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in Round 10 following major revision.
  • Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.

The Board approved “in principle” all proposals in Categories 1, 2 and 2B. However, some of the approvals are immediate and some are delayed, depending on future availability of funds. The prioritization is handled as follows:

  • Category 1 and Category 2 proposals are approved immediately.
  • Each country submitting a proposal rated Category 2B is assigned a disease burden index of 4 or 1 according to whether the disease burden is “very high” or not “very high”. And each such country is assigned a poverty index of 4, 2 or 0 according to whether the country is low income, lower-middle income, or upper-middle income. The sum of these two indexes creates the Composite Index, whose value is therefore between 8 and 1. The higher the country’s Composite Index, the sooner its Category 2B proposal will be approved.
  • Category 2B proposals will be approved in the following order, as pledges by donors to the Fund become available in the course of 2009-2010:
    1. Category 2B, Composite Index 8
    2. Category 2B, Composite Index 6
    3. Category 2B, Composite Index 5
    4. Category 2B, Composite Index 4
    5. Category 2B, Composite Index 3

The number of Round 9 grants per Category and Composite Index are as follows:

 

Table 5: Round 9 results by Category and Composite Index

Category and Composite Index Number of proposals Amount

requested (Years 1-2)

Immediate approval: Category 1 5 $0.14 b.
Immediate approval: Category 2 49 $1.35 b.
Delayed approval: Category 2B, Composite Index 8 9 $0.32 b.
Delayed approval: Category 2B, Composite Index 6 6 $0.17 b.
Delayed approval: Category 2B, Composite Index 5 6 $0.15 b.
Delayed approval: Category 2B, Composite Index 4 1 $0.00 b.
Delayed approval: Category 2B, Composite Index 3 9 $0.08 b.
Subtotal: All Approved Proposals: 85 $2.21 b.
Not Approved: Category 3 64 $2.08 b.
Not Approved: Category 4 10 $0.19 b.
Not Approved: Removed sub-components of approved proposals n/a $0.37 b.
Subtotal: All Non-Approved Proposals: 74 $2.63 b.
Total: All Proposals 159 $4.85 b.

Round 9 results by applicant were as in Tables 6 and 7, below.

Table 6: Round 9 Results, by Country

 

Note that for each grant, the final amount that will be approved will be on average at least 10% lower than the amount requested for years 1-2, and potentially up to 25% lower for years 3-5.

Country Disease component Applicant type Decision Category

(defined above)

Composite Index

(defined above)

Amount

requested (Years 1-2)

Amount requested (Years 1-5)
Afghanistan HIV (disease part + HSS part) CCM Not approved 3 n/a USD17,157,661 USD48,857,724
Albania HIV CCM Not approved 3 n/a USD8,097,017 USD13,275,254
Albania TB CCM Not approved 3 n/a USD2,482,523 USD5,226,962
Angola HIV CCM Not approved 3 n/a USD37,442,140 USD138,112,093
Angola TB CCM Delayed approval 2B 6 USD11,384,314 USD25,766,362
Azerbaijan HIV CCM Immediate approval 2 n/a EUR11,831,706 EUR26,983,960
Azerbaijan TB CCM Immediate approval 2 n/a EUR1,983,042 EUR5,065,216
Bangladesh Malaria CCM Immediate approval 2 n/a USD10,280,071 USD43,649,545
Belarus TB CCM Immediate approval 2 n/a USD10,127,774 USD24,679,591
Belize HIV (disease part + HSS part) CCM Delayed approval 2B 4 USD3,190,410 USD6,053,270
Benin HIV (disease part + HSS part) CCM Immediate approval 2 n/a EUR48,272,734 EUR108,636,826
Benin TB CCM Immediate approval 2 n/a EUR2,813,599 EUR4,815,146
Bhutan HIV CCM Not approved 3 n/a USD1,277,902 USD3,429,344
Bolivia HIV CCM Immediate approval 2 n/a USD9,501,866 USD26,267,794
Bolivia TB CCM Immediate approval 2 n/a USD4,379,037 USD9,833,163
Bosnia & Herzegovina HIV CCM Immediate approval 2 n/a EUR14,428,659 EUR32,453,777
Bosnia & Herzegovina TB CCM Delayed approval 2B 3 EUR7,287,274 EUR15,007,449
Botswana HIV CCM Not approved 3 n/a USD22,137,763 USD75,677,032
Brazil TB CCM Not approved 3 n/a EUR26,499,742 EUR57,157,477
Brazil HIV CCM Not approved 3 n/a EUR13,097,142 EUR30,940,720
Burkina Faso HIV (disease part + HSS part) CCM Not approved 3 n/a EUR49,925,705 EUR160,561,226
Burundi Malaria CCM Immediate approval 2 n/a USD21,578,809 USD60,448,200
Cambodia HIV (disease part + HSS part) CCM Immediate approval 2 n/a USD63,502,281 USD165,087,396
Cambodia Malaria CCM Immediate approval 1 n/a USD43,717,857 USD102,033,561
Cameroon HIV CCM Not approved 3 n/a EUR41,336,332 EUR121,255,912
Cameroon Malaria CCM Immediate approval 2 n/a EUR77,791,996 EUR113,983,337
Cameroon TB CCM Immediate approval 2 n/a EUR6,823,011 EUR15,422,473
Central African Republic TB CCM Delayed approval 2B 8 EUR12,167,295 EUR29,782,006
Chad HIV (disease part + HSS part) CCM Not approved 3 n/a EUR36,087,457 EUR57,040,882
Chad Malaria CCM Immediate approval 2 n/a EUR20,807,913 EUR29,993,968
Chad TB CCM Not approved 3 n/a EUR4,409,888 EUR8,658,158
China * TB (disease part + HSS part) CCM Delayed approval 2B 6 USD76,075,195 USD239,655,469
Colombia HIV CCM Delayed approval 2B 6 EUR16,659,253 EUR42,317,779
Colombia TB CCM Not approved 3 n/a EUR6,981,414 EUR13,155,213
Comoros HIV (disease part + HSS part) CCM Immediate approval 2 n/a EUR1,833,520 EUR3,107,636
Congo (Democratic Republic of) HIV CCM Not approved 3 n/a USD42,987,274 USD94,181,440
Congo (Democratic Republic of) Malaria CCM Not approved 3 n/a USD117,708,841 USD280,495,135
Congo (Democratic Republic of) TB (disease part + HSS part) CCM Delayed approval 2B 8 USD110,092,302 USD306,794,269
Congo (Republic of) HIV CCM Delayed approval 2B 6 EUR10,773,466 EUR27,447,268
Cote d’Ivoire HIV (disease part) CCM Immediate approval 2 n/a EUR46,066,302 EUR125,953,322
Cote d’Ivoire HIV (HSS part) CCM Not approved n/a n/a EUR43,810,725 EUR97,590,298
Cote d’Ivoire TB CCM Immediate approval 2 n/a EUR9,672,256 EUR33,977,331
Djibouti HIV CCM Not approved 3 n/a EUR4,609,238 EUR15,739,214
Djibouti Malaria CCM Delayed approval 2B 3 EUR2,342,193 EUR6,591,356
Djibouti TB CCM Not approved 3 n/a EUR1,847,708 EUR5,069,930
Dominican Republic HIV CCM Not approved 3 n/a USD16,796,759 USD49,481,694
Ecuador HIV CCM Immediate approval 2 n/a USD10,813,915 USD27,922,499
Ecuador TB CCM Immediate approval 2 n/a USD6,834,160 USD13,736,572
El Salvador TB CCM Immediate approval 2 n/a USD3,588,887 USD7,810,938
Eritrea Malaria (disease part + HSS part) CCM Immediate approval 1 n/a USD29,855,990 USD69,433,635
Ethiopia HIV CCM Not approved 3 n/a USD38,910,498 USD87,776,761
Ethiopia TB (disease part) CCM Not approved n/a n/a USD35,441,974 USD99,748,261
Ethiopia TB (HSS part) CCM Delayed approval 2B 8 USD19,383,242 USD38,601,776
Fiji HIV (disease part) CCM Not approved n/a n/a USD4,567,641 USD11,032,725
Fiji HIV (HSS part) CCM Immediate approval 2 n/a USD1,242,510 USD2,075,508
Gambia Malaria CCM Immediate approval 2 n/a USD10,611,436 USD26,346,040
Gambia TB CCM Delayed approval 2B 5 USD8,049,144 USD15,626,486
Georgia HIV CCM Immediate approval 1 n/a EUR7,209,605 EUR12,826,501
Georgia TB CCM Not approved 3 n/a EUR6,334,105 EUR15,198,017
Ghana TB (disease part + HSS part) CCM Not approved 3 n/a USD35,221,971 USD78,630,160
Guatemala Malaria CCM Immediate approval 2 n/a USD21,452,001 USD42,171,298
Guinea Malaria CCM Not approved 3 n/a USD41,713,830 USD136,406,368
Guinea TB CCM Immediate approval 2 n/a USD4,035,589 USD10,736,627
Guinea HIV (disease part + HSS part) CCM Not approved 3 n/a USD47,536,996 USD133,700,829
Guinea-Bissau Malaria (disease part + HSS part) CCM Immediate approval 2 n/a EUR6,145,091 EUR13,492,563
Guinea-Bissau TB CCM Delayed approval 2B 5 EUR7,179,501 EUR14,553,382
Haiti TB CCM Delayed approval 2B 8 USD12,260,870 USD27,669,547
Honduras HIV CCM Immediate approval 2 n/a USD9,821,491 USD21,899,375
Honduras TB CCM Not approved 3 n/a USD4,644,621 USD7,973,129
India HIV CCM Delayed approval 2B 8 USD21,000,206 USD78,712,640
India Malaria CCM Delayed approval 2B 5 USD38,105,605 USD113,680,179
India TB CCM Immediate approval 2 n/a USD69,477,410 USD199,544,948
Indonesia HIV (disease part) CCM Immediate approval 2 n/a USD27,723,275 USD87,142,130
Indonesia HIV (HSS part) CCM Not approved n/a n/a USD16,211,864 USD34,683,394
Iraq TB CCM Delayed approval 2B 3 USD14,670,783 USD28,785,292
Kenya Malaria CCM Not approved 3 n/a USD173,151,886 USD270,264,819
Kenya * TB CCM Delayed approval 2B 8 USD23,682,114 USD50,661,608
Korea (Democratic People’s Republic of) HIV CCM Not approved 4 n/a EUR3,621,666 EUR10,260,105
Kosovo TB CCM Delayed approval 2B 3 EUR2,784,907 EUR5,821,665
Kyrgyz Republic TB CCM Delayed approval 2B 5 USD7,811,886 USD26,273,558
Lesotho HIV CCM Immediate approval 2 n/a USD10,356,112 USD30,796,293
Liberia TB CCM Not approved 3 n/a USD24,337,864 USD54,637,458
Macedonia, FYR TB CCM Not approved 3 n/a EUR2,406,848 EUR4,846,058
Malawi Malaria CCM Immediate approval 2 n/a USD33,170,946 USD94,006,593
Malawi TB (disease part + HSS part) CCM Not approved 3 n/a USD16,586,861 USD34,091,794
Malaysia HIV CCM Not approved 3 n/a EUR16,914,686 EUR55,470,594
Mali Malaria CCM Not approved 3 n/a EUR78,261,962 EUR174,578,758
Mexico HIV CCM Immediate approval 2 n/a USD31,008,826 USD76,492,174
Moldova HIV CCM Not approved 3 n/a EUR6,632,255 EUR6,632,255
Moldova TB CCM Delayed approval 2B 3 EUR5,271,784 EUR10,099,233
Mongolia HIV (disease part) CCM Not approved n/a n/a USD2,117,412 USD5,236,283
Mongolia HIV (HSS part) CCM Immediate approval 2 n/a USD2,780,049 USD4,223,964
Montenegro HIV CCM Delayed approval 2B 3 EUR2,547,414 EUR5,164,889
Montenegro TB CCM Not approved 3 n/a EUR1,079,081 EUR1,825,708
Mozambique HIV (disease part) CCM Delayed approval 2B 8 USD69,377,979 USD175,774,009
Mozambique HIV (HSS part) CCM Not approved n/a n/a USD32,700,132 USD87,121,662
Mozambique Malaria CCM Immediate approval 2 n/a USD67,401,102 USD157,490,802
Myanmar HIV CCM Immediate approval 1 n/a USD51,716,207 USD157,776,471
Myanmar Malaria CCM Immediate approval 2 n/a USD37,578,282 USD77,384,020
Myanmar TB CCM Immediate approval 2 n/a USD34,024,424 USD85,520,947
Nepal HIV CCM Not approved 3 n/a USD10,250,156 USD33,295,636
Nicaragua Malaria CCM Delayed approval 2B 3 USD4,299,868 USD8,204,092
Niger HIV CCM Not approved 3 n/a EUR12,273,273 EUR35,668,229
Niger Malaria CCM Not approved 3 n/a EUR14,774,509 EUR60,296,247
Niger TB (disease part + HSS part) CCM Not approved 3 n/a EUR28,683,728 EUR51,445,595
Nigeria HIV CCM Immediate approval 2 n/a USD61,980,496 USD341,019,908
Nigeria TB CCM Delayed approval 2B 8 USD31,515,160 USD113,332,101
Pakistan HIV (disease part + HSS part) CCM Not approved 3 n/a USD34,771,776 USD101,928,849
Pakistan Malaria CCM Not approved 3 n/a USD22,058,072 USD38,444,514
Pakistan TB CCM Immediate approval 2 n/a USD40,146,549 USD173,045,676
Panama HIV (disease part + HSS part) CCM Not approved 3 n/a USD8,681,679 USD19,791,821
Papua New Guinea HIV (disease part + HSS part) CCM Not approved 3 n/a USD37,755,778 USD108,875,287
Paraguay HIV (disease part) CCM Not approved n/a n/a USD6,924,331 USD16,738,249
Paraguay HIV (HSS part) CCM Immediate approval 2 n/a USD6,463,831 USD12,735,212
Paraguay TB CCM Immediate approval 2 n/a USD2,080,336 USD3,974,941
Peru Malaria CCM Not approved 3 n/a EUR12,287,854 EUR23,978,876
Russian Federation TB CCM Not approved 4 n/a EUR39,148,932 EUR139,266,200
Russian Federation TB Sub-CCM Not approved 4 n/a EUR25,586,216 EUR46,500,983
São Tomé and Príncipe HIV CCM Not approved 3 n/a USD3,388,782 USD5,893,968
Senegal * HIV (disease part + HSS part) CCM Immediate approval 2 n/a EUR29,125,467 EUR88,751,831
Senegal Malaria CCM Not approved 3 n/a EUR13,463,444 EUR43,391,628
Senegal TB CCM Not approved 3 n/a EUR5,439,361 EUR15,223,424
Serbia * TB CCM Immediate approval 1 n/a USD3,441,632 USD7,540,351
Sierra Leone HIV (disease part + HSS part) CCM Immediate approval 2 n/a USD35,159,372 USD86,543,306
Sierra Leone Malaria CCM Not approved 3 n/a USD46,897,411 USD121,926,865
Solomon Islands HIV CCM Not approved 3 n/a USD6,896,921 USD17,219,358
South Africa HIV CCM Immediate approval 2 n/a USD42,577,518 USD108,974,360
Sri Lanka HIV (disease part + HSS part) CCM Delayed approval 2B 3 USD19,398,656 USD34,901,359
Sudan South HIV (disease part) Sub-CCM Not approved n/a n/a USD59,977,815 USD143,281,740
Sudan South HIV (HSS part) Sub-CCM Immediate approval 2 n/a USD27,230,100 USD52,572,614
Sudan South Malaria CCM Not approved 3 n/a USD47,848,374 USD130,852,071
Suriname HIV CCM Not approved 3 n/a USD13,973,874 USD30,918,273
Suriname TB CCM Immediate approval 2 n/a USD3,112,254 USD5,765,300
Syria HIV (disease part + HSS part) CCM Not approved 4 n/a USD12,748,562 USD25,664,260
Syria TB CCM Not approved 4 n/a USD4,632,686 USD9,343,366
Tanzania HIV (disease part) CCM Not approved n/a n/a USD141,703,169 USD299,064,874
Tanzania HIV (HSS part) CCM Immediate approval 2 n/a USD97,901,945 USD176,089,978
Tanzania Malaria CCM Delayed approval 2B 5 USD76,050,523 USD173,612,609
Tanzania TB CCM Not approved 3 n/a USD44,045,185 USD99,426,802
Thailand HIV CCM Not approved 3 n/a USD22,903,685 USD68,935,356
Thailand Malaria CCM Not approved 3 n/a USD32,327,332 USD75,648,892
Togo HIV CCM Not approved 3 n/a EUR19,855,192 EUR54,839,797
Togo Malaria (disease part) CCM Immediate approval 2 n/a EUR41,116,176 EUR70,116,448
Togo Malaria (HSS part) CCM Not approved n/a n/a EUR2,424,256 EUR5,369,974
Togo TB CCM Not approved 4 n/a EUR1,904,955 EUR1,904,955
Turkmenistan TB (disease part) CCM Delayed approval 2B 3 USD7,268,169 USD19,186,023
Turkmenistan TB (HSS part) CCM Not approved n/a n/a USD181,777 USD289,542
Uganda HIV CCM Not approved 3 n/a USD200,824,716 USD411,140,514
Uganda Malaria (disease part + HSS part) CCM Not approved 3 n/a USD135,054,987 USD376,353,583
Uganda TB CCM Not approved 3 n/a USD20,327,175 USD32,684,978
Ukraine TB CCM Not approved 3 n/a USD34,584,205 USD103,459,618
Uruguay HIV CCM Not approved 3 n/a USD7,679,330 USD24,664,893
Vietnam * HIV CCM Immediate approval 2 n/a USD27,363,443 USD101,950,596
Vietnam TB CCM Delayed approval 2B 8 USD19,124,977 USD59,392,208
Yemen HIV CCM Not approved 3 n/a USD10,943,780 USD25,246,321
Yemen TB CCM Delayed approval 2B 5 USD11,136,828 USD24,769,339
Zambia HIV CCM Not approved 3 n/a USD26,111,595 USD142,597,930
Zambia Malaria CCM Not approved 3 n/a USD21,843,651 USD54,966,386

* Note that for Kenya TB, Senegal HIV, Serbia TB and Vietnam HIV, the amount requested is less than was in the proposal because the TRP removed certain elements from the proposal. Also for China TB the recommended amount was adjusted for other technical reasons.

 

Table 7: Round 9 results for regional applicants

Applicant Disease Applicant type Decision Category

(defined above)

Composite Index

(defined above)

Requested (Years 1-2) Requested (Years 1-5)
AfriCASO (re Benin, Cameroon, Central African Republic, Gabon, Gambia, Liberia) HIV Regional organisation Not approved 3 n/a EUR5,894,744 EUR13,672,440
Andean Regional Coordinating Mechanism (re Chile, Peru, Colombia, Bolivia, Ecuador, Venezuela) HIV Regional Coordinating Mechanism Not approved 4 n/a EUR19,820,520 EUR40,189,363
CCLAB (re Guatemala, El Salvador, Honduras, Nicaragua, Costa Rica, Panama) HIV Regional Coordinating Mechanism Not approved 3 n/a USD11,123,412 USD18,721,697
COPRECOS LAC (re Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Nicaragua, Panama, Paraguay, Peru, Uruguay, Venezuela) HIV Regional organisation Delayed approval 2B 6 USD17,599,678 USD58,889,550
Mano River Union (re Côte d’Ivoire, Guinea, Liberia, Sierra Leone) HIV Regional organisation Not approved 4 n/a USD21,688,571 USD36,300,171
MENAHRA (re Afghanistan, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Morocco, Oman, West Bank and Gaza, Pakistan, Syrian Arab Republic, Tunisia) HIV Regional organisation Not approved 3 n/a USD15,196,689 USD32,966,023
Naz Foundation Int. (re Afghanistan, Bangladesh, Bhutan, India, Nepal, Pakistan, Sri Lanka) HIV Regional organisation Immediate approval 2 n/a USD18,660,775 USD47,002,257
PANCAP-CARICOM (re Haiti, Dominican Republic, Guyana, Jamaica, Suriname, Belize, Dominica, Grenada, St. Lucia, St Vincent and the Grenadines, Dominica, Antigua and Barbuda, Bahamas, Barbados, Montserrat, St. Kitts and Nevis, Trinidad and Tobago) HIV Regional Coordinating Mechanism Immediate approval 2 n/a USD14,458,896 USD34,527,244
REDCARD (re Costa Rica, Dominican Republic, El Salvador, Guatemala, Honduras, Nicaragua, Panama) HIV Regional organisation Not approved 4 n/a USD8,667,612 USD31,042,376
RedTraSex (re Argentina, Bolivia, Brazil, Chile, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay) HIV Regional organisation Not approved 3 n/a USD7,580,751 USD18,140,937
SADC (re Angola, Botswana , Namibia, Zambia, Zimbabwe) Malaria Regional organisation Not approved 4 n/a USD8,183,343 USD12,571,057
SADC (re Angola, Botswana, Congo (Democratic Republic), Lesotho, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Swaziland , United Republic of Tanzania, Zambia, Zimbabwe) HIV Regional organisation Delayed approval 2B 6 USD24,587,661 USD44,982,085

Leave a Reply

Your email address will not be published.

Aidspan

Categories*

Loading
Aidspan

Categories*

Loading